Oklahoma SB1658 creates the Informed Consent and Medical Transparency Act, requiring drug manufacturers to provide clear summaries of side effects.
Oklahoma SB1658, the Informed Consent and Medical Transparency Act, mandates drug manufacturers to prepare plain-language summaries of known side effects and adverse events, ensuring they are understandable to both health care providers and patients. Hospitals and health care providers must ensure patients receive this information. The act allows patients injured due to noncompliance to bring civil actions for damages. It also authorizes the Attorney General or any district attorney to bring actions under the Oklahoma Consumer Protection Act for patterns of noncompliance.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.